1. Introduction

The biotech, health, and pharma industries are experiencing accelerated growth at both global and regional levels, creating a demand for innovative digital solutions that integrate data, artificial intelligence, and clinical processes. From Puente BIO, we propose a tailored program designed for software factories seeking to explore and validate new business lines focused on this sector.

2. Program Objective

To guide the software factory through six practical and strategic sessions in order to:

• Understand the biotech/health/pharma market and its opportunities.

• Design and validate a new business line or digital product.

• Incorporate bioinformatics as a strategic differentiator.

• Define an implementation roadmap and a clear go-to-market strategy.

3. Program Structure (6 sessions, 2 hours each)

1. Introduction & Opportunities in Biotech:
   Overview of the biotech and health landscape. Introduction to bioinformatics as a field for developers.

2. Understanding the Client & Opportunity Detection:
   Mapping the biotech client journey. Identifying bioinformatics needs within the industry.

3. Solution Ideation:
   Generating digital solution ideas. Integrating bioinformatics as added value.

4. Validation & Business Model:
   Competitive benchmarking. Rapid validation. Value proposition and business model design. Should you create an internal bioinformatics unit?

5. Roadmap & Go-to-Market:
   MVP roadmap design. Strategies to train or attract bioinformaticians. Initial commercialization.

6. Final Presentation & Feedback:
   Pitch of the new business line or product, highlighting differentiation through bioinformatics. Feedback panel with experts.

Expected Outcomes

• Identification of a concrete niche within biotech/health/pharma.

• Design of a viable digital solution for that niche.

• Definition of value proposition, business model, and MVP roadmap.

• Initial go-to-market strategy.

• Strategy for incorporating bioinformaticians into the software factory.

5. Investment

To be defined according to the number of participants per company.
(Includes six sessions, working materials, facilitation, and feedback from guest experts.)

6. Why Puente BIO

• Proven experience bridging the tech and biotech worlds.

• Practical methodology with tangible deliverables in every session.

• Network of contacts across biotech, health, and pharma in Latin America.

• A distinctive focus on bioinformatics as a strategic bridge.